These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38904958)
21. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. Pijls NH; Fearon WF; Tonino PA; Siebert U; Ikeno F; Bornschein B; van't Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; De Bruyne B; J Am Coll Cardiol; 2010 Jul; 56(3):177-84. PubMed ID: 20537493 [TBL] [Abstract][Full Text] [Related]
22. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease. Choi KH; Lee JM; Koo BK; Nam CW; Shin ES; Doh JH; Rhee TM; Hwang D; Park J; Zhang J; Kim KJ; Hu X; Wang J; Ye F; Chen S; Yang J; Chen J; Tanaka N; Yokoi H; Matsuo H; Takashima H; Shiono Y; Akasaka T JACC Cardiovasc Interv; 2018 Feb; 11(3):237-245. PubMed ID: 29361444 [TBL] [Abstract][Full Text] [Related]
23. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease. Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067 [TBL] [Abstract][Full Text] [Related]
24. Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease. Sud M; Han L; Koh M; Austin PC; Farkouh ME; Ly HQ; Madan M; Natarajan MK; So DY; Wijeysundera HC; Fang J; Ko DT JAMA; 2020 Dec; 324(23):2406-2414. PubMed ID: 33185655 [TBL] [Abstract][Full Text] [Related]
25. Impact of impaired fractional flow reserve after coronary interventions on outcomes: a systematic review and meta-analysis. Wolfrum M; Fahrni G; de Maria GL; Knapp G; Curzen N; Kharbanda RK; Fröhlich GM; Banning AP BMC Cardiovasc Disord; 2016 Sep; 16(1):177. PubMed ID: 27608682 [TBL] [Abstract][Full Text] [Related]
26. Physiology- or Imaging-Guided Strategies for Intermediate Coronary Stenosis. Yang S; Kang J; Hwang D; Zhang J; Jiang J; Hu X; Hahn JY; Nam CW; Doh JH; Lee BK; Kim W; Huang J; Jiang F; Zhou H; Chen P; Tang L; Jiang W; Chen X; He W; Ahn SG; Yoon MH; Kim U; Lee JM; Ki YJ; Shin ES; Kim HS; Tahk SJ; Wang J; Koo BK JAMA Netw Open; 2024 Jan; 7(1):e2350036. PubMed ID: 38170524 [TBL] [Abstract][Full Text] [Related]
27. Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure. Uretsky BF; Agarwal SK; Vallurupalli S; Al-Hawwas M; Miller K; Biscaglia S; Hakeem A JACC Cardiovasc Interv; 2022 Nov; 15(21):2192-2202. PubMed ID: 36357023 [TBL] [Abstract][Full Text] [Related]
28. Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve. Kim J; Shin D; Lee JM; Lee SH; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ; van de Hoef TP; JACC Cardiovasc Interv; 2022 May; 15(10):1033-1043. PubMed ID: 35490124 [TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation. Piroth Z; Toth GG; Tonino PAL; Barbato E; Aghlmandi S; Curzen N; Rioufol G; Pijls NHJ; Fearon WF; Jüni P; De Bruyne B Circ Cardiovasc Interv; 2017 Aug; 10(8):. PubMed ID: 28790165 [TBL] [Abstract][Full Text] [Related]
30. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961 [TBL] [Abstract][Full Text] [Related]
31. Relationship between fractional flow reserve and residual plaque volume and clinical outcomes after optimal drug-eluting stent implantation: insight from intravascular ultrasound volumetric analysis. Ito T; Tani T; Fujita H; Ohte N Int J Cardiol; 2014 Sep; 176(2):399-404. PubMed ID: 25125008 [TBL] [Abstract][Full Text] [Related]
32. Effect of Coronary Disease Characteristics on Prognostic Relevance of Residual Ischemia After Stent Implantation. Yang S; Zhang J; Hwang D; Lee JM; Nam CW; Shin ES; Doh JH; Hoshino M; Hamaya R; Kanaji Y; Murai T; Zhang JJ; Ye F; Li X; Ge Z; Chen SL; Kakuta T; Koo BK Front Cardiovasc Med; 2021; 8():696756. PubMed ID: 34950710 [No Abstract] [Full Text] [Related]